世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

腫瘍マーカーイムノアッセイの世界市場の洞察と2028年までの予測


Global Tumor Markers Immunoassay Market Insights and Forecast to 2028

市場分析と洞察。腫瘍マーカーイムノアッセイの世界市場 腫瘍マーカー免疫測定法の世界市場規模は、2021年の百万米ドルから2028年には百万米ドルに達すると予測され、2022年から2028年の間、年率％で推移すると... もっと見る

　

　

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ 		2022年1月28日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

市場分析と洞察。腫瘍マーカーイムノアッセイの世界市場
腫瘍マーカー免疫測定法の世界市場規模は、2021年の百万米ドルから2028年には百万米ドルに達すると予測され、2022年から2028年の間、年率％で推移すると考えられます。
この健康危機による経済的変化を十分に考慮し、2021年に腫瘍マーカー免疫測定法の世界市場の％を占めていたProGRPは、COVID-19後の期間に改訂された％CAGRで成長し、2028年には100万米ドルになると予測されています。一方、肝臓がんのセグメントは、この予測期間中、％のCAGRで変化しています。
中国の腫瘍マーカー免疫測定法の市場規模は2021年に百万米ドル、北米と欧州の腫瘍マーカー免疫測定法の市場規模はそれぞれ百万米ドルと百万米ドルとなっています。2021年の北米の割合は%で、中国とヨーロッパはそれぞれ%と%で、中国の割合は2028年に%に達し、分析期間中のCAGRは%になると予測されています。アジアでは、日本、韓国、東南アジアが注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。欧州の腫瘍マーカーイムノアッセイ市場では、ドイツが2028年までに100万米ドルに達すると予測されており、予測期間中のCAGRは%です。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界の腫瘍マーカー免疫測定市場で得られる主要な機会を明らかにし、市場での確固たる地位を獲得するために役立つようにしています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができ、その中には、収益面での世界のTumor Markers Immunoassay市場全体のサイズに関する予測も含まれています。
本レポートは、競合他社に対して優位に立ち、世界のTumor Markers Immunoassay市場で永続的な成功を収めるための効果的なツールであることを証明しています。本レポートに掲載されている調査結果、データ、情報はすべて、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界のTumor Markers Immunoassay市場を詳細に調査するために、独自の業界最高水準の調査・分析手法を用いています。
世界の腫瘍マーカー免疫測定法の範囲と市場規模
腫瘍マーカー免疫測定法の市場は、プレイヤー別、地域（国）別、タイプ別、アプリケーション別に分類されています。世界のTumor Markers Immunoassay市場のプレーヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の収益と予測に焦点を当てています。
タイプ別セグメント
プロGRP
PSA（複合型、遊離型、総型）)
SCC(扁平上皮癌抗原)
血清中のHER-2/neu
サイログロブリン
CA 72-4
その他
用途別セグメント
肝臓がん
乳がん
その他
会社別
クラリティ・ダイアグノスティックス社
CTKバイオテック社
DIALAB社
オルソ・クリニカル・ダイアグノスティックス社
Polymedco, Inc.
DIAsource ImmunoAssays SA
DRGインターナショナル株式会社
富士レビオUS社
バイオサイエンス（天津）診断技術有限公司
ボソンバイオテック株式会社
クオリジェン社
ランドックス・ラボラトリーズ株式会社
ロシュ・ダイアグノスティック・コーポレーション
シーメンス・ヘルシネアーズ
シントロン・バイオリサーチ社
テコ・ダイアグノスティックス
サーモフィッシャーサイエンティフィック社
東ソー・バイオサイエンス株式会社
ディアメトラ
DiaSorin S.p.A
地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧諸国
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域


ページTOPに戻る


目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Markers Immunoassay Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 ProGRP
1.2.3 PSA (complexed, free, total))
1.2.4 SCC (squamous cell carcinoma antigen)
1.2.5 Serum HER-2/neu
1.2.6 Thyroglobulin
1.2.7 CA 72-4
1.2.8 Others
1.3 Market by Application
1.3.1 Global Tumor Markers Immunoassay Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Liver Cancer
1.3.3 Breast Cancer
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Tumor Markers Immunoassay Market Perspective (2017-2028)
2.2 Tumor Markers Immunoassay Growth Trends by Region
2.2.1 Tumor Markers Immunoassay Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Tumor Markers Immunoassay Historic Market Size by Region (2017-2022)
2.2.3 Tumor Markers Immunoassay Forecasted Market Size by Region (2023-2028)
2.3 Tumor Markers Immunoassay Market Dynamics
2.3.1 Tumor Markers Immunoassay Industry Trends
2.3.2 Tumor Markers Immunoassay Market Drivers
2.3.3 Tumor Markers Immunoassay Market Challenges
2.3.4 Tumor Markers Immunoassay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Markers Immunoassay Players by Revenue
3.1.1 Global Top Tumor Markers Immunoassay Players by Revenue (2017-2022)
3.1.2 Global Tumor Markers Immunoassay Revenue Market Share by Players (2017-2022)
3.2 Global Tumor Markers Immunoassay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tumor Markers Immunoassay Revenue
3.4 Global Tumor Markers Immunoassay Market Concentration Ratio
3.4.1 Global Tumor Markers Immunoassay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Markers Immunoassay Revenue in 2021
3.5 Tumor Markers Immunoassay Key Players Head office and Area Served
3.6 Key Players Tumor Markers Immunoassay Product Solution and Service
3.7 Date of Enter into Tumor Markers Immunoassay Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Markers Immunoassay Breakdown Data by Type
4.1 Global Tumor Markers Immunoassay Historic Market Size by Type (2017-2022)
4.2 Global Tumor Markers Immunoassay Forecasted Market Size by Type (2023-2028)
5 Tumor Markers Immunoassay Breakdown Data by Application
5.1 Global Tumor Markers Immunoassay Historic Market Size by Application (2017-2022)
5.2 Global Tumor Markers Immunoassay Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Tumor Markers Immunoassay Market Size (2017-2028)
6.2 North America Tumor Markers Immunoassay Market Size by Type
6.2.1 North America Tumor Markers Immunoassay Market Size by Type (2017-2022)
6.2.2 North America Tumor Markers Immunoassay Market Size by Type (2023-2028)
6.2.3 North America Tumor Markers Immunoassay Market Share by Type (2017-2028)
6.3 North America Tumor Markers Immunoassay Market Size by Application
6.3.1 North America Tumor Markers Immunoassay Market Size by Application (2017-2022)
6.3.2 North America Tumor Markers Immunoassay Market Size by Application (2023-2028)
6.3.3 North America Tumor Markers Immunoassay Market Share by Application (2017-2028)
6.4 North America Tumor Markers Immunoassay Market Size by Country
6.4.1 North America Tumor Markers Immunoassay Market Size by Country (2017-2022)
6.4.2 North America Tumor Markers Immunoassay Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Tumor Markers Immunoassay Market Size (2017-2028)
7.2 Europe Tumor Markers Immunoassay Market Size by Type
7.2.1 Europe Tumor Markers Immunoassay Market Size by Type (2017-2022)
7.2.2 Europe Tumor Markers Immunoassay Market Size by Type (2023-2028)
7.2.3 Europe Tumor Markers Immunoassay Market Share by Type (2017-2028)
7.3 Europe Tumor Markers Immunoassay Market Size by Application
7.3.1 Europe Tumor Markers Immunoassay Market Size by Application (2017-2022)
7.3.2 Europe Tumor Markers Immunoassay Market Size by Application (2023-2028)
7.3.3 Europe Tumor Markers Immunoassay Market Share by Application (2017-2028)
7.4 Europe Tumor Markers Immunoassay Market Size by Country
7.4.1 Europe Tumor Markers Immunoassay Market Size by Country (2017-2022)
7.4.2 Europe Tumor Markers Immunoassay Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Markers Immunoassay Market Size (2017-2028)
8.2 Asia-Pacific Tumor Markers Immunoassay Market Size by Type
8.2.1 Asia-Pacific Tumor Markers Immunoassay Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Tumor Markers Immunoassay Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Tumor Markers Immunoassay Market Share by Type (2017-2028)
8.3 Asia-Pacific Tumor Markers Immunoassay Market Size by Application
8.3.1 Asia-Pacific Tumor Markers Immunoassay Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Tumor Markers Immunoassay Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Tumor Markers Immunoassay Market Share by Application (2017-2028)
8.4 Asia-Pacific Tumor Markers Immunoassay Market Size by Region
8.4.1 Asia-Pacific Tumor Markers Immunoassay Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Tumor Markers Immunoassay Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Tumor Markers Immunoassay Market Size (2017-2028)
9.2 Latin America Tumor Markers Immunoassay Market Size by Type
9.2.1 Latin America Tumor Markers Immunoassay Market Size by Type (2017-2022)
9.2.2 Latin America Tumor Markers Immunoassay Market Size by Type (2023-2028)
9.2.3 Latin America Tumor Markers Immunoassay Market Share by Type (2017-2028)
9.3 Latin America Tumor Markers Immunoassay Market Size by Application
9.3.1 Latin America Tumor Markers Immunoassay Market Size by Application (2017-2022)
9.3.2 Latin America Tumor Markers Immunoassay Market Size by Application (2023-2028)
9.3.3 Latin America Tumor Markers Immunoassay Market Share by Application (2017-2028)
9.4 Latin America Tumor Markers Immunoassay Market Size by Country
9.4.1 Latin America Tumor Markers Immunoassay Market Size by Country (2017-2022)
9.4.2 Latin America Tumor Markers Immunoassay Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Markers Immunoassay Market Size (2017-2028)
10.2 Middle East & Africa Tumor Markers Immunoassay Market Size by Type
10.2.1 Middle East & Africa Tumor Markers Immunoassay Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Tumor Markers Immunoassay Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Tumor Markers Immunoassay Market Share by Type (2017-2028)
10.3 Middle East & Africa Tumor Markers Immunoassay Market Size by Application
10.3.1 Middle East & Africa Tumor Markers Immunoassay Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Tumor Markers Immunoassay Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Tumor Markers Immunoassay Market Share by Application (2017-2028)
10.4 Middle East & Africa Tumor Markers Immunoassay Market Size by Country
10.4.1 Middle East & Africa Tumor Markers Immunoassay Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Tumor Markers Immunoassay Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Clarity Diagnostics, LLC
11.1.1 Clarity Diagnostics, LLC Company Details
11.1.2 Clarity Diagnostics, LLC Business Overview
11.1.3 Clarity Diagnostics, LLC Tumor Markers Immunoassay Introduction
11.1.4 Clarity Diagnostics, LLC Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.1.5 Clarity Diagnostics, LLC Recent Developments
11.2 CTK Biotech, Inc
11.2.1 CTK Biotech, Inc Company Details
11.2.2 CTK Biotech, Inc Business Overview
11.2.3 CTK Biotech, Inc Tumor Markers Immunoassay Introduction
11.2.4 CTK Biotech, Inc Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.2.5 CTK Biotech, Inc Recent Developments
11.3 DIALAB GmbH
11.3.1 DIALAB GmbH Company Details
11.3.2 DIALAB GmbH Business Overview
11.3.3 DIALAB GmbH Tumor Markers Immunoassay Introduction
11.3.4 DIALAB GmbH Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.3.5 DIALAB GmbH Recent Developments
11.4 Ortho Clinical Diagnostics
11.4.1 Ortho Clinical Diagnostics Company Details
11.4.2 Ortho Clinical Diagnostics Business Overview
11.4.3 Ortho Clinical Diagnostics Tumor Markers Immunoassay Introduction
11.4.4 Ortho Clinical Diagnostics Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.4.5 Ortho Clinical Diagnostics Recent Developments
11.5 Polymedco, Inc
11.5.1 Polymedco, Inc Company Details
11.5.2 Polymedco, Inc Business Overview
11.5.3 Polymedco, Inc Tumor Markers Immunoassay Introduction
11.5.4 Polymedco, Inc Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.5.5 Polymedco, Inc Recent Developments
11.6 DIAsource ImmunoAssays SA
11.6.1 DIAsource ImmunoAssays SA Company Details
11.6.2 DIAsource ImmunoAssays SA Business Overview
11.6.3 DIAsource ImmunoAssays SA Tumor Markers Immunoassay Introduction
11.6.4 DIAsource ImmunoAssays SA Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.6.5 DIAsource ImmunoAssays SA Recent Developments
11.7 DRG International, Inc
11.7.1 DRG International, Inc Company Details
11.7.2 DRG International, Inc Business Overview
11.7.3 DRG International, Inc Tumor Markers Immunoassay Introduction
11.7.4 DRG International, Inc Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.7.5 DRG International, Inc Recent Developments
11.8 Fujirebio US, Inc
11.8.1 Fujirebio US, Inc Company Details
11.8.2 Fujirebio US, Inc Business Overview
11.8.3 Fujirebio US, Inc Tumor Markers Immunoassay Introduction
11.8.4 Fujirebio US, Inc Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.8.5 Fujirebio US, Inc Recent Developments
11.9 Bioscience (Tianjin) Diagnostic Technology Co., Ltd
11.9.1 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Company Details
11.9.2 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Business Overview
11.9.3 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Tumor Markers Immunoassay Introduction
11.9.4 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.9.5 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Recent Developments
11.10 Boson Biotech Co., Ltd
11.10.1 Boson Biotech Co., Ltd Company Details
11.10.2 Boson Biotech Co., Ltd Business Overview
11.10.3 Boson Biotech Co., Ltd Tumor Markers Immunoassay Introduction
11.10.4 Boson Biotech Co., Ltd Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.10.5 Boson Biotech Co., Ltd Recent Developments
11.11 Qualigen, Inc
11.11.1 Qualigen, Inc Company Details
11.11.2 Qualigen, Inc Business Overview
11.11.3 Qualigen, Inc Tumor Markers Immunoassay Introduction
11.11.4 Qualigen, Inc Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.11.5 Qualigen, Inc Recent Developments
11.12 Randox Laboratories, Ltd
11.12.1 Randox Laboratories, Ltd Company Details
11.12.2 Randox Laboratories, Ltd Business Overview
11.12.3 Randox Laboratories, Ltd Tumor Markers Immunoassay Introduction
11.12.4 Randox Laboratories, Ltd Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.12.5 Randox Laboratories, Ltd Recent Developments
11.13 Roche Diagnostic Corporation
11.13.1 Roche Diagnostic Corporation Company Details
11.13.2 Roche Diagnostic Corporation Business Overview
11.13.3 Roche Diagnostic Corporation Tumor Markers Immunoassay Introduction
11.13.4 Roche Diagnostic Corporation Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.13.5 Roche Diagnostic Corporation Recent Developments
11.14 Siemens Healthineers
11.14.1 Siemens Healthineers Company Details
11.14.2 Siemens Healthineers Business Overview
11.14.3 Siemens Healthineers Tumor Markers Immunoassay Introduction
11.14.4 Siemens Healthineers Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.14.5 Siemens Healthineers Recent Developments
11.15 Syntron Bioresearch, Inc
11.15.1 Syntron Bioresearch, Inc Company Details
11.15.2 Syntron Bioresearch, Inc Business Overview
11.15.3 Syntron Bioresearch, Inc Tumor Markers Immunoassay Introduction
11.15.4 Syntron Bioresearch, Inc Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.15.5 Syntron Bioresearch, Inc Recent Developments
11.16 Teco Diagnostics
11.16.1 Teco Diagnostics Company Details
11.16.2 Teco Diagnostics Business Overview
11.16.3 Teco Diagnostics Tumor Markers Immunoassay Introduction
11.16.4 Teco Diagnostics Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.16.5 Teco Diagnostics Recent Developments
11.17 Thermo Fisher Scientific, Inc
11.17.1 Thermo Fisher Scientific, Inc Company Details
11.17.2 Thermo Fisher Scientific, Inc Business Overview
11.17.3 Thermo Fisher Scientific, Inc Tumor Markers Immunoassay Introduction
11.17.4 Thermo Fisher Scientific, Inc Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.17.5 Thermo Fisher Scientific, Inc Recent Developments
11.18 Tosoh Bioscience, Inc
11.18.1 Tosoh Bioscience, Inc Company Details
11.18.2 Tosoh Bioscience, Inc Business Overview
11.18.3 Tosoh Bioscience, Inc Tumor Markers Immunoassay Introduction
11.18.4 Tosoh Bioscience, Inc Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.18.5 Tosoh Bioscience, Inc Recent Developments
11.19 Diametra
11.19.1 Diametra Company Details
11.19.2 Diametra Business Overview
11.19.3 Diametra Tumor Markers Immunoassay Introduction
11.19.4 Diametra Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.19.5 Diametra Recent Developments
11.20 DiaSorin S.p.A
11.20.1 DiaSorin S.p.A Company Details
11.20.2 DiaSorin S.p.A Business Overview
11.20.3 DiaSorin S.p.A Tumor Markers Immunoassay Introduction
11.20.4 DiaSorin S.p.A Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.20.5 DiaSorin S.p.A Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

　

ページTOPに戻る


　

Summary

Market Analysis and Insights: Global Tumor Markers Immunoassay Market
The global Tumor Markers Immunoassay market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, ProGRP accounting for % of the Tumor Markers Immunoassay global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Liver Cancer segment is altered to an % CAGR throughout this forecast period.
China Tumor Markers Immunoassay market size is valued at US$ million in 2021, while the North America and Europe Tumor Markers Immunoassay are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Tumor Markers Immunoassay landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tumor Markers Immunoassay market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tumor Markers Immunoassay market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tumor Markers Immunoassay market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tumor Markers Immunoassay market.
Global Tumor Markers Immunoassay Scope and Market Size
Tumor Markers Immunoassay market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Tumor Markers Immunoassay market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
ProGRP
PSA (complexed, free, total))
SCC (squamous cell carcinoma antigen)
Serum HER-2/neu
Thyroglobulin
CA 72-4
Others
Segment by Application
Liver Cancer
Breast Cancer
Others
By Company
Clarity Diagnostics, LLC
CTK Biotech, Inc
DIALAB GmbH
Ortho Clinical Diagnostics
Polymedco, Inc
DIAsource ImmunoAssays SA
DRG International, Inc
Fujirebio US, Inc
Bioscience (Tianjin) Diagnostic Technology Co., Ltd
Boson Biotech Co., Ltd
Qualigen, Inc
Randox Laboratories, Ltd
Roche Diagnostic Corporation
Siemens Healthineers
Syntron Bioresearch, Inc
Teco Diagnostics
Thermo Fisher Scientific, Inc
Tosoh Bioscience, Inc
Diametra
DiaSorin S.p.A
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA



ページTOPに戻る


Table of Contents

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Markers Immunoassay Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 ProGRP
1.2.3 PSA (complexed, free, total))
1.2.4 SCC (squamous cell carcinoma antigen)
1.2.5 Serum HER-2/neu
1.2.6 Thyroglobulin
1.2.7 CA 72-4
1.2.8 Others
1.3 Market by Application
1.3.1 Global Tumor Markers Immunoassay Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Liver Cancer
1.3.3 Breast Cancer
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Tumor Markers Immunoassay Market Perspective (2017-2028)
2.2 Tumor Markers Immunoassay Growth Trends by Region
2.2.1 Tumor Markers Immunoassay Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Tumor Markers Immunoassay Historic Market Size by Region (2017-2022)
2.2.3 Tumor Markers Immunoassay Forecasted Market Size by Region (2023-2028)
2.3 Tumor Markers Immunoassay Market Dynamics
2.3.1 Tumor Markers Immunoassay Industry Trends
2.3.2 Tumor Markers Immunoassay Market Drivers
2.3.3 Tumor Markers Immunoassay Market Challenges
2.3.4 Tumor Markers Immunoassay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Markers Immunoassay Players by Revenue
3.1.1 Global Top Tumor Markers Immunoassay Players by Revenue (2017-2022)
3.1.2 Global Tumor Markers Immunoassay Revenue Market Share by Players (2017-2022)
3.2 Global Tumor Markers Immunoassay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tumor Markers Immunoassay Revenue
3.4 Global Tumor Markers Immunoassay Market Concentration Ratio
3.4.1 Global Tumor Markers Immunoassay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Markers Immunoassay Revenue in 2021
3.5 Tumor Markers Immunoassay Key Players Head office and Area Served
3.6 Key Players Tumor Markers Immunoassay Product Solution and Service
3.7 Date of Enter into Tumor Markers Immunoassay Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Markers Immunoassay Breakdown Data by Type
4.1 Global Tumor Markers Immunoassay Historic Market Size by Type (2017-2022)
4.2 Global Tumor Markers Immunoassay Forecasted Market Size by Type (2023-2028)
5 Tumor Markers Immunoassay Breakdown Data by Application
5.1 Global Tumor Markers Immunoassay Historic Market Size by Application (2017-2022)
5.2 Global Tumor Markers Immunoassay Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Tumor Markers Immunoassay Market Size (2017-2028)
6.2 North America Tumor Markers Immunoassay Market Size by Type
6.2.1 North America Tumor Markers Immunoassay Market Size by Type (2017-2022)
6.2.2 North America Tumor Markers Immunoassay Market Size by Type (2023-2028)
6.2.3 North America Tumor Markers Immunoassay Market Share by Type (2017-2028)
6.3 North America Tumor Markers Immunoassay Market Size by Application
6.3.1 North America Tumor Markers Immunoassay Market Size by Application (2017-2022)
6.3.2 North America Tumor Markers Immunoassay Market Size by Application (2023-2028)
6.3.3 North America Tumor Markers Immunoassay Market Share by Application (2017-2028)
6.4 North America Tumor Markers Immunoassay Market Size by Country
6.4.1 North America Tumor Markers Immunoassay Market Size by Country (2017-2022)
6.4.2 North America Tumor Markers Immunoassay Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Tumor Markers Immunoassay Market Size (2017-2028)
7.2 Europe Tumor Markers Immunoassay Market Size by Type
7.2.1 Europe Tumor Markers Immunoassay Market Size by Type (2017-2022)
7.2.2 Europe Tumor Markers Immunoassay Market Size by Type (2023-2028)
7.2.3 Europe Tumor Markers Immunoassay Market Share by Type (2017-2028)
7.3 Europe Tumor Markers Immunoassay Market Size by Application
7.3.1 Europe Tumor Markers Immunoassay Market Size by Application (2017-2022)
7.3.2 Europe Tumor Markers Immunoassay Market Size by Application (2023-2028)
7.3.3 Europe Tumor Markers Immunoassay Market Share by Application (2017-2028)
7.4 Europe Tumor Markers Immunoassay Market Size by Country
7.4.1 Europe Tumor Markers Immunoassay Market Size by Country (2017-2022)
7.4.2 Europe Tumor Markers Immunoassay Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Markers Immunoassay Market Size (2017-2028)
8.2 Asia-Pacific Tumor Markers Immunoassay Market Size by Type
8.2.1 Asia-Pacific Tumor Markers Immunoassay Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Tumor Markers Immunoassay Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Tumor Markers Immunoassay Market Share by Type (2017-2028)
8.3 Asia-Pacific Tumor Markers Immunoassay Market Size by Application
8.3.1 Asia-Pacific Tumor Markers Immunoassay Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Tumor Markers Immunoassay Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Tumor Markers Immunoassay Market Share by Application (2017-2028)
8.4 Asia-Pacific Tumor Markers Immunoassay Market Size by Region
8.4.1 Asia-Pacific Tumor Markers Immunoassay Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Tumor Markers Immunoassay Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Tumor Markers Immunoassay Market Size (2017-2028)
9.2 Latin America Tumor Markers Immunoassay Market Size by Type
9.2.1 Latin America Tumor Markers Immunoassay Market Size by Type (2017-2022)
9.2.2 Latin America Tumor Markers Immunoassay Market Size by Type (2023-2028)
9.2.3 Latin America Tumor Markers Immunoassay Market Share by Type (2017-2028)
9.3 Latin America Tumor Markers Immunoassay Market Size by Application
9.3.1 Latin America Tumor Markers Immunoassay Market Size by Application (2017-2022)
9.3.2 Latin America Tumor Markers Immunoassay Market Size by Application (2023-2028)
9.3.3 Latin America Tumor Markers Immunoassay Market Share by Application (2017-2028)
9.4 Latin America Tumor Markers Immunoassay Market Size by Country
9.4.1 Latin America Tumor Markers Immunoassay Market Size by Country (2017-2022)
9.4.2 Latin America Tumor Markers Immunoassay Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Markers Immunoassay Market Size (2017-2028)
10.2 Middle East & Africa Tumor Markers Immunoassay Market Size by Type
10.2.1 Middle East & Africa Tumor Markers Immunoassay Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Tumor Markers Immunoassay Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Tumor Markers Immunoassay Market Share by Type (2017-2028)
10.3 Middle East & Africa Tumor Markers Immunoassay Market Size by Application
10.3.1 Middle East & Africa Tumor Markers Immunoassay Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Tumor Markers Immunoassay Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Tumor Markers Immunoassay Market Share by Application (2017-2028)
10.4 Middle East & Africa Tumor Markers Immunoassay Market Size by Country
10.4.1 Middle East & Africa Tumor Markers Immunoassay Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Tumor Markers Immunoassay Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Clarity Diagnostics, LLC
11.1.1 Clarity Diagnostics, LLC Company Details
11.1.2 Clarity Diagnostics, LLC Business Overview
11.1.3 Clarity Diagnostics, LLC Tumor Markers Immunoassay Introduction
11.1.4 Clarity Diagnostics, LLC Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.1.5 Clarity Diagnostics, LLC Recent Developments
11.2 CTK Biotech, Inc
11.2.1 CTK Biotech, Inc Company Details
11.2.2 CTK Biotech, Inc Business Overview
11.2.3 CTK Biotech, Inc Tumor Markers Immunoassay Introduction
11.2.4 CTK Biotech, Inc Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.2.5 CTK Biotech, Inc Recent Developments
11.3 DIALAB GmbH
11.3.1 DIALAB GmbH Company Details
11.3.2 DIALAB GmbH Business Overview
11.3.3 DIALAB GmbH Tumor Markers Immunoassay Introduction
11.3.4 DIALAB GmbH Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.3.5 DIALAB GmbH Recent Developments
11.4 Ortho Clinical Diagnostics
11.4.1 Ortho Clinical Diagnostics Company Details
11.4.2 Ortho Clinical Diagnostics Business Overview
11.4.3 Ortho Clinical Diagnostics Tumor Markers Immunoassay Introduction
11.4.4 Ortho Clinical Diagnostics Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.4.5 Ortho Clinical Diagnostics Recent Developments
11.5 Polymedco, Inc
11.5.1 Polymedco, Inc Company Details
11.5.2 Polymedco, Inc Business Overview
11.5.3 Polymedco, Inc Tumor Markers Immunoassay Introduction
11.5.4 Polymedco, Inc Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.5.5 Polymedco, Inc Recent Developments
11.6 DIAsource ImmunoAssays SA
11.6.1 DIAsource ImmunoAssays SA Company Details
11.6.2 DIAsource ImmunoAssays SA Business Overview
11.6.3 DIAsource ImmunoAssays SA Tumor Markers Immunoassay Introduction
11.6.4 DIAsource ImmunoAssays SA Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.6.5 DIAsource ImmunoAssays SA Recent Developments
11.7 DRG International, Inc
11.7.1 DRG International, Inc Company Details
11.7.2 DRG International, Inc Business Overview
11.7.3 DRG International, Inc Tumor Markers Immunoassay Introduction
11.7.4 DRG International, Inc Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.7.5 DRG International, Inc Recent Developments
11.8 Fujirebio US, Inc
11.8.1 Fujirebio US, Inc Company Details
11.8.2 Fujirebio US, Inc Business Overview
11.8.3 Fujirebio US, Inc Tumor Markers Immunoassay Introduction
11.8.4 Fujirebio US, Inc Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.8.5 Fujirebio US, Inc Recent Developments
11.9 Bioscience (Tianjin) Diagnostic Technology Co., Ltd
11.9.1 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Company Details
11.9.2 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Business Overview
11.9.3 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Tumor Markers Immunoassay Introduction
11.9.4 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.9.5 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Recent Developments
11.10 Boson Biotech Co., Ltd
11.10.1 Boson Biotech Co., Ltd Company Details
11.10.2 Boson Biotech Co., Ltd Business Overview
11.10.3 Boson Biotech Co., Ltd Tumor Markers Immunoassay Introduction
11.10.4 Boson Biotech Co., Ltd Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.10.5 Boson Biotech Co., Ltd Recent Developments
11.11 Qualigen, Inc
11.11.1 Qualigen, Inc Company Details
11.11.2 Qualigen, Inc Business Overview
11.11.3 Qualigen, Inc Tumor Markers Immunoassay Introduction
11.11.4 Qualigen, Inc Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.11.5 Qualigen, Inc Recent Developments
11.12 Randox Laboratories, Ltd
11.12.1 Randox Laboratories, Ltd Company Details
11.12.2 Randox Laboratories, Ltd Business Overview
11.12.3 Randox Laboratories, Ltd Tumor Markers Immunoassay Introduction
11.12.4 Randox Laboratories, Ltd Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.12.5 Randox Laboratories, Ltd Recent Developments
11.13 Roche Diagnostic Corporation
11.13.1 Roche Diagnostic Corporation Company Details
11.13.2 Roche Diagnostic Corporation Business Overview
11.13.3 Roche Diagnostic Corporation Tumor Markers Immunoassay Introduction
11.13.4 Roche Diagnostic Corporation Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.13.5 Roche Diagnostic Corporation Recent Developments
11.14 Siemens Healthineers
11.14.1 Siemens Healthineers Company Details
11.14.2 Siemens Healthineers Business Overview
11.14.3 Siemens Healthineers Tumor Markers Immunoassay Introduction
11.14.4 Siemens Healthineers Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.14.5 Siemens Healthineers Recent Developments
11.15 Syntron Bioresearch, Inc
11.15.1 Syntron Bioresearch, Inc Company Details
11.15.2 Syntron Bioresearch, Inc Business Overview
11.15.3 Syntron Bioresearch, Inc Tumor Markers Immunoassay Introduction
11.15.4 Syntron Bioresearch, Inc Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.15.5 Syntron Bioresearch, Inc Recent Developments
11.16 Teco Diagnostics
11.16.1 Teco Diagnostics Company Details
11.16.2 Teco Diagnostics Business Overview
11.16.3 Teco Diagnostics Tumor Markers Immunoassay Introduction
11.16.4 Teco Diagnostics Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.16.5 Teco Diagnostics Recent Developments
11.17 Thermo Fisher Scientific, Inc
11.17.1 Thermo Fisher Scientific, Inc Company Details
11.17.2 Thermo Fisher Scientific, Inc Business Overview
11.17.3 Thermo Fisher Scientific, Inc Tumor Markers Immunoassay Introduction
11.17.4 Thermo Fisher Scientific, Inc Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.17.5 Thermo Fisher Scientific, Inc Recent Developments
11.18 Tosoh Bioscience, Inc
11.18.1 Tosoh Bioscience, Inc Company Details
11.18.2 Tosoh Bioscience, Inc Business Overview
11.18.3 Tosoh Bioscience, Inc Tumor Markers Immunoassay Introduction
11.18.4 Tosoh Bioscience, Inc Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.18.5 Tosoh Bioscience, Inc Recent Developments
11.19 Diametra
11.19.1 Diametra Company Details
11.19.2 Diametra Business Overview
11.19.3 Diametra Tumor Markers Immunoassay Introduction
11.19.4 Diametra Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.19.5 Diametra Recent Developments
11.20 DiaSorin S.p.A
11.20.1 DiaSorin S.p.A Company Details
11.20.2 DiaSorin S.p.A Business Overview
11.20.3 DiaSorin S.p.A Tumor Markers Immunoassay Introduction
11.20.4 DiaSorin S.p.A Revenue in Tumor Markers Immunoassay Business (2017-2022)
11.20.5 DiaSorin S.p.A Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

QYResearch社のその他分野での最新刊レポート

本レポートと同じKEY WORD（immunoassay）の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22　10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.